4//SEC Filing
Vellanki Avanish 4
Accession 0000899243-22-020666
CIK 0001724979other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:05 PM ET
Size
5.0 KB
Accession
0000899243-22-020666
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2022-06-01$2.29/sh+25,000$57,250→ 2,471,627 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $2.285 to $2.3268. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Rain Therapeutics Inc.
CIK 0001724979
Entity typeother
Related Parties
1- filerCIK 0001856682
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:05 PM ET
- Size
- 5.0 KB